A group representing compounding pharmacies has filed a lawsuit against the US Food and Drug Administration, arguing that the ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...

Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...

Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also ...

The FDA declared the shortage of Novo Nordisk's weight-loss drugs over, giving compounders until May to stop making alternatives. An industry group representing compounders is suing. Dr. Angela Fitch ...

The WEGOVY market has experienced significant growth, driven by rising obesity rates and increasing demand for effective weight-loss treatments. Novo Nordisk's blockbuster drug has seen strong ...

Lexaria executing a triple-pronged strategy in obesity and diabetesSemaglutide recently approved to treat chronic kidney disease KELOWNA, BC / ACCESS Newswire / February 27, 2025 / Lexaria Bioscience ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

ProRx Pharma, the wellness and longevity 503B outsourcing facility, has announced the expansion of its operations to help meet the demand for critical medications?now and into the future with a full ...

With Kennedy now in the driver's seat, the industry will likely expect more: It aims to make bolder health claims for its ...

With egg prices soaring, the US is considering vaccinating laying chickens, which have been hit particularly hard by the ...

Scott Disick was seemingly surprised to learn that his Mounjaro weight-loss medications made a cameo on 'The Kardashians.' Khloe Kardashian advises to her sister's ex to "hide your drugs." ...